Takahashi T, Kinoshita T, Shigemi D, Imanishi Y, Sakamoto M, Ichimiya M
Vaccine X. 2025; 22():100599.
PMID: 39802325
PMC: 11719379.
DOI: 10.1016/j.jvacx.2024.100599.
Latifi M, Alishan Karami N, Allahbakhshian L, Aghaesmaeili N, Tehrani H
Int J Prev Med. 2024; 15:41.
PMID: 39381357
PMC: 11460987.
DOI: 10.4103/ijpvm.ijpvm_337_23.
Nakamura K, Kigure K, Nishimura T, Yamashita S
BMC Womens Health. 2024; 24(1):402.
PMID: 39014425
PMC: 11251239.
DOI: 10.1186/s12905-024-03256-z.
Yagi A, Ueda Y, Oka E, Nakagawa S, Kimura T
JAMA Netw Open. 2024; 7(7):e2422513.
PMID: 39012629
PMC: 11252895.
DOI: 10.1001/jamanetworkopen.2024.22513.
Phongsamart W, Lou P, Sukarom I, Wu Y, Zaidi O, Du F
Hum Vaccin Immunother. 2024; 20(1):2362449.
PMID: 38925146
PMC: 11210899.
DOI: 10.1080/21645515.2024.2362449.
Even though active recommendation for HPV vaccination has restarted, Japan's rates have not recovered.
Yagi A, Ueda Y, Oka E, Nakagawa S, Kimura T, Shimoya K
Cancer Sci. 2024; 115(7):2410-2416.
PMID: 38698561
PMC: 11247556.
DOI: 10.1111/cas.16167.
A comprehensive narrative review of challenges and facilitators in the implementation of various HPV vaccination program worldwide.
Aggarwal S, Agarwal P, Gupta N
Cancer Med. 2024; 13(3):e6862.
PMID: 38213086
PMC: 10911072.
DOI: 10.1002/cam4.6862.
Effectiveness of catch-up and routine program of the 9-valent vaccine on cervical cancer risk reduction in Japan.
Yagi A, Nakagawa S, Ueda Y, Oka E, Ikeda S, Kakuda M
Cancer Sci. 2023; 115(3):916-925.
PMID: 38158850
PMC: 10920980.
DOI: 10.1111/cas.16055.
Intentions for catch-up HPV vaccination in Japan: an internet survey.
Nakagawa S, Yagi A, Ueda Y, Ikeda S, Kakuda M, Hiramatsu K
Int J Clin Oncol. 2023; 28(12):1667-1679.
PMID: 37776388
PMC: 10687105.
DOI: 10.1007/s10147-023-02411-0.
Etiology, diagnosis, treatment, and prevention of human papilloma virus-associated oropharyngeal squamous cell carcinoma.
Shinomiya H, Nibu K
Int J Clin Oncol. 2023; 28(8):975-981.
PMID: 37093464
PMC: 10390603.
DOI: 10.1007/s10147-023-02336-8.
Disparities among Japanese municipalities in recommendations for routine and catch-up HPV vaccinations.
Watanabe Y, Ueda Y, Yagi A, Ikeda S, Oka E, Kakuda M
Cancer Sci. 2023; 114(5):2139-2144.
PMID: 36747329
PMC: 10154824.
DOI: 10.1111/cas.15748.
Updates on HPV Vaccination.
Illah O, Olaitan A
Diagnostics (Basel). 2023; 13(2).
PMID: 36673053
PMC: 9857409.
DOI: 10.3390/diagnostics13020243.
Can Catch-Up Vaccinations Fill the Void Left by Suspension of the Governmental Recommendation of HPV Vaccine in Japan?.
Yagi A, Ueda Y, Nakagawa S, Ikeda S, Kakuda M, Hiramatsu K
Vaccines (Basel). 2022; 10(9).
PMID: 36146533
PMC: 9502134.
DOI: 10.3390/vaccines10091455.
Effectiveness of human papillomavirus vaccine against cervical precancer in Japan: Multivariate analyses adjusted for sexual activity.
Kudo R, Sekine M, Yamaguchi M, Hara M, Hanley S, Kurosawa M
Cancer Sci. 2022; 113(9):3211-3220.
PMID: 35730321
PMC: 9459348.
DOI: 10.1111/cas.15471.